PURPOSE: This study examined the complication rates associated with percutaneous fiducial placement for the purpose of stereotactic body radiation therapy of primary and metastatic lung neoplasms. PATIENTS AND METHODS: This is a retrospective review of computed tomography (CT) scans and follow-up chest radiographs of 48 consecutive patients who underwent CT-guided percutaneous fiducial placement. The effect of age, sex, number of fiducials placed, and performance of a concomitant biopsy on the complication rates were assessed. RESULTS: Of 48 patients with a total of 221 fiducials placed, 16 (33%) had a procedure-related pneumothorax. There was no significant difference in pneumothorax rate based on age (P = 0.16), sex (P > 0.99), and number of fiducials placed (P = 0.21). Overall, 6 of 48 patients (12.5%) required a thoracostomy tube. Performance of a concomitant core needle biopsy at the time of fiducial placement was associated with pneumothorax rates of 64% compared with 26% without biopsies (P = 0.03). Postprocedural CT demonstrated hemorrhage in 9 patients (19%). Two patients had hemoptysis; one required admission. Patients' age, sex, number of fiducials placed, and performance of concomitant biopsy had no statistically significant implications on parenchymal hemorrhage incidence. CONCLUSION: Approximately one third of the patients develop a pneumothorax during CT-guided fiducial placement. Most are asymptomatic and do not require a thoracostomy. A concurrent biopsy at the time of fiducial placement is associated with an increased risk of pneumothorax. Hemorrhage occurs but is usually clinically insignificant.
PURPOSE: This study examined the complication rates associated with percutaneous fiducial placement for the purpose of stereotactic body radiation therapy of primary and metastatic lung neoplasms. PATIENTS AND METHODS: This is a retrospective review of computed tomography (CT) scans and follow-up chest radiographs of 48 consecutive patients who underwent CT-guided percutaneous fiducial placement. The effect of age, sex, number of fiducials placed, and performance of a concomitant biopsy on the complication rates were assessed. RESULTS: Of 48 patients with a total of 221 fiducials placed, 16 (33%) had a procedure-related pneumothorax. There was no significant difference in pneumothorax rate based on age (P = 0.16), sex (P > 0.99), and number of fiducials placed (P = 0.21). Overall, 6 of 48 patients (12.5%) required a thoracostomy tube. Performance of a concomitant core needle biopsy at the time of fiducial placement was associated with pneumothorax rates of 64% compared with 26% without biopsies (P = 0.03). Postprocedural CT demonstrated hemorrhage in 9 patients (19%). Two patients had hemoptysis; one required admission. Patients' age, sex, number of fiducials placed, and performance of concomitant biopsy had no statistically significant implications on parenchymal hemorrhage incidence. CONCLUSION: Approximately one third of the patients develop a pneumothorax during CT-guided fiducial placement. Most are asymptomatic and do not require a thoracostomy. A concurrent biopsy at the time of fiducial placement is associated with an increased risk of pneumothorax. Hemorrhage occurs but is usually clinically insignificant.
Authors: Nikhil Bhagat; Nicholas Fidelman; Jeremy C Durack; Jeremy Collins; Roy L Gordon; Jeanne M LaBerge; Robert K Kerlan Journal: Cardiovasc Intervent Radiol Date: 2010-07-27 Impact factor: 2.740
Authors: Chaitan K Narsule; Praveen Sridhar; Divya Nair; Avneesh Gupta; Roy G Oommen; Michael I Ebright; Virginia R Litle; Hiran C Fernando Journal: J Thorac Dis Date: 2017-10 Impact factor: 2.895
Authors: James W Snider; Eric K Oermann; Viola Chen; Jennifer Rabin; Simeng Suy; Xia Yu; Saloomeh Vahdat; Sean P Collins; Filip Banovac; Eric Anderson; Brian T Collins Journal: Front Oncol Date: 2012-06-29 Impact factor: 6.244
Authors: Viola J Chen; Eric Oermann; Saloomeh Vahdat; Jennifer Rabin; Simeng Suy; Xia Yu; Sean P Collins; Deepa Subramaniam; Filip Banovac; Eric Anderson; Brian T Collins Journal: Front Oncol Date: 2012-02-01 Impact factor: 6.244
Authors: Brian T Collins; Saloomeh Vahdat; Kelly Erickson; Sean P Collins; Simeng Suy; Xia Yu; Ying Zhang; Deepa Subramaniam; Cristina A Reichner; Ismet Sarikaya; Giuseppe Esposito; Shadi Yousefi; Carlos Jamis-Dow; Filip Banovac; Eric D Anderson Journal: J Hematol Oncol Date: 2009-01-17 Impact factor: 17.388
Authors: Brian T Collins; Kelly Erickson; Cristina A Reichner; Sean P Collins; Gregory J Gagnon; Sonja Dieterich; Don A McRae; Ying Zhang; Shadi Yousefi; Elliot Levy; Thomas Chang; Carlos Jamis-Dow; Filip Banovac; Eric D Anderson Journal: Radiat Oncol Date: 2007-10-22 Impact factor: 3.481
Authors: Yi Rong; Jose G Bazan; Ashley Sekhon; Karl Haglund; Meng Xu-Welliver; Terence Williams Journal: PLoS One Date: 2015-07-09 Impact factor: 3.240